CENTILUK TABLET
  • Share this portfolio
  • Previous Portfolio
  • Next Portfolio
  • Portfolio List
  • Close Video

CENTILUK TABLET

September 7, 2016

Composition:
Centiluk Tablet:

Montelukast Sodium 10 mg + Levocetirizine Dihyrochloride 5 mg Bilayer Tablet

Centiluk Suspension:
Each 5 ml contains Montelukast Sodium 4 mg + Levocetirizine Dihyrochloride 52.5 mg

Indications:
• Allergic rhinitis; seasonal and perennial
• Prophylaxis and maintenance of asthma with allergic rhinitis

Dosage:
• Adults: One tablet OD in the evening.
• For the children of 2-5 years – 2.5 ml is given once daily in the evening.
• For the children of 6-11 years- 5 ml is given once daily in the evening.
• For the children of 12 years & above -10 ml is given once daily in the evening.

Adverse events: Dyspepsia, abdominal pain, rash, dizziness, headache, fatigue, somnolence, hypersensitivity, irritability, restlessness, insomnia, vomiting, diarrhea.

Contraindications: Hypersensitivity to any component of the product, severe renal impairment (creatinine clearance <10mL/min). Precautions: Use with caution in patients with severe impairment of hepatic function, pregnant and lactating women.